Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly Lymphoma Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03711110
What this trial is testing

Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)

Who this might be right for
Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)ElderlyAntineoplastic Agents+1 more
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León 514
Testing effectiveness (Phase 2)UnknownNCT04688983
What this trial is testing

Study in Adult Ph-positive ALL

Who this might be right for
Acute Lymphoblastic Leukemia, Adult
Cardiff University 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05214183
What this trial is testing

Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma

Who this might be right for
MCLMantle Cell Lymphoma
Nordic Lymphoma Group 81
Early research (Phase 1)Study completedNCT01132573
What this trial is testing

Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia

Who this might be right for
Acute Leukemias of Ambiguous LineagePhiladelphia Chromosome Negative Adult Precursor Acute Lymphoblastic LeukemiaRecurrent Adult Acute Lymphoblastic Leukemia+1 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Looking for participantsNCT05245656
What this trial is testing

A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Kim, Seok Jin 90
Testing effectiveness (Phase 2)Looking for participantsNCT06136351
What this trial is testing

The Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma, Mantle-Cell
Ruijin Hospital 23
Testing effectiveness (Phase 2)Study completedNCT01958996
What this trial is testing

Phase I/II Study of Escalating Doses of Idarubicin Orally Given With Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patient With Disseminated High Grade Non Hodgkin Lymphoma

Who this might be right for
High Grade Lymphomas CD20 Positive
Poitiers University Hospital 27
Large-scale testing (Phase 3)Ended earlyNCT00140660
What this trial is testing

ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large Cell Lymphoma
Lymphoma Study Association 223
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07739459
What this trial is testing

Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
The Lymphoma Academic Research Organisation 95
Not applicableActive Not RecruitingNCT07374068
What this trial is testing

Prognostic Model of Elderly Hodgkin Lymphoma in China

Who this might be right for
Hodgkin Lymphoma
Tianjin Medical University Cancer Institute and Hospital 400
Testing effectiveness (Phase 2)Ended earlyNCT00120198
What this trial is testing

Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

Who this might be right for
Non-Hodgkin's Lymphoma
Geriatric Oncology Consortium 50
Large-scale testing (Phase 3)Looking for participantsNCT04442412
What this trial is testing

Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy

Who this might be right for
Diffuse Large B-Cell LymphomaElderly Patients
Fondazione Italiana Linfomi - ETS 430
Testing effectiveness (Phase 2)Study completedNCT03677154
What this trial is testing

Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Hoffmann-La Roche 188
Post-approval studies (Phase 4)UnknownNCT03513601
What this trial is testing

Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Mingzhi Zhang 20
Testing effectiveness (Phase 2)UnknownNCT01670370
What this trial is testing

Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL.

Who this might be right for
Diffuse Large B-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 60
Early research (Phase 1)Study completedNCT01431664
What this trial is testing

AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Leukemia
Cancer Research UK 7
Not applicableUnknownNCT02888977
What this trial is testing

Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL

Who this might be right for
Lymphoblastic Leukemia, Acute
Versailles Hospital 100
Testing effectiveness (Phase 2)UnknownNCT03949062
What this trial is testing

Study Evaluating the Safety and Efficacy of iR2 in Untreated and Unfit Elderly Patients With DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00850512
What this trial is testing

Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy

Who this might be right for
Diffuse Large B-Cell Lymphoma
University of Bologna 55
Post-approval studies (Phase 4)UnknownNCT01366898
What this trial is testing

Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)

Who this might be right for
Acute Lymphoblastic Leukemia
PETHEMA Foundation 100
Next Page